Skip to main content

23 October 2025

Last updated: Thursday 23 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Due diligence is more than a numbers game

Friday 27 April 2012

Interviewee/Contributor

Anthony Sedgwick

Organisation

Silence Therapeutics Plc

Organisations

Anergis SA
Novo Seeds
Food and Drug Administration
International Society Cell and Gene Therapy
Nanobiotix SA
ReiThera Srl
Infectious Diseases Society of America (IDSA)
ReNeuron Group Plc
Forbion
European Forum for Good Clinical Practice

Interviewees and Contributers

Vasiliki Nikolaou and David Haddleton
Nicholas Adams
Oliver Rausch
Mark Watterson
Tony Woodgate
Stephan Christgau
Stéphane Degove
Kai Uwe Bindseil
Roger Pertwee
Rafiq Hasan

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form